Discussions on Long-Listed Drugs Must Balance Interests of All Stakeholders

June 14, 2012
The Central Social Insurance Medical Council’s (CSIMC) Expert Subcommittee on NHI Drug Pricing Affairs started discussions on the pricing of long-listed drugs on June 6. The discussions will focus on whether the NHI prices of long-listed drugs should be reduced...read more